Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Update on bTB vaccine

MPs warn vaccine is not a complete solution

In a report published on June 5, the Environment, Food and Rural Affairs Committee (EFRACom), warned that vaccination will not provide a complete solution to bovine TB (bTB).

Launching the report into the progress of a vaccine, EFRACom chair Anne McIntosh said vaccination is expensive, does not guarantee protection and will not on its own solve the problems caused by bTB.

"The Government is right to invest millions of pounds in developing vaccines against bovine TB. We should use every tool to combat this disease, but vaccination alone will not, at least in the short-term, provide a complete solution.

"Vaccines have no impact on already infected animals, offer a range of protection to those that aren’t infected, and will be expensive to deploy."

Small-scale studies in Ethiopia and Mexico have found the protective effect of a cattle vaccine to be 56-68 per cent. EFRACom warn that this is not a high enough level of protection to immediately solve the problem.

The injectable badger vaccine, which has been available since 2010, "could create a healthier badger population", according to Ms McIntosh. It is, however, expensive, she added, meaning it should be used in areas where it will have the most impact.

An oral baited badger vaccine is felt to be "the most likely way to create a healthy badger population," offering a cheaper and more practical alternative to vaccination.

Concluding, Ms McIntosh called on the government to investigate whether the gamma interferon test - a blood test that is more sensitive than the skin test currently relied upon - could be used more widely to test for bTB, despite the cost.

She added that ongoing research projects could make a real difference in eradicating the disease in the UK, and the government's continuing investment in this research is crucial.

 

Related News
Reseach offers hope for bTB vaccine
Cattle bTB vaccine unlikely until 2023

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.